Pathological tau aggregation is a primary neuropathological feature of many
neurodegenerative diseases. Intriguingly, despite the common presence of tau aggregates …

Alzheimer's disease (AD) is a prevalent neurodegenerative disease characterized by both
amnestic and non-amnestic clinical manifestations. It accounts for approximately 60-70% of …

The pathological features of PDD are represented by dopaminergic neuronal death and
intracellular α‐synuclein (α‐syn) aggregation. The interaction of iron accumulation with α …

Abstract Multiple System Atrophy (MSA) and Progressive Supranuclear Palsy (PSP) are
atypical parkinsonian syndromes (APS) with various clinical phenotypes and considerable …

The field of Alzheimer's disease (AD) has witnessed recent breakthroughs in the
development of disease-modifying biologics and diagnostic markers. While …

Neurodegenerative diseases, tauopathies, constitute a serious global health problem. The
etiology of these diseases is unclear and an increase in their incidence has been projected …

Background: Pathological tau proteins constitute neurofibrillary tangles that accumulate in
tauopathies including Alzheimer's disease (AD), progressive supranuclear palsy (PSP), and …

Traumatic brain injury is followed by a cascade of dynamic and complex events occurring at
the cellular level. These events include: diffuse axonal injury, neuronal cell death, blood …

Simple Summary Tauopathies is a term coined to describe an umbrella of disorders
characterized by abnormal Tau polypeptide deposits in neurons, glial cells, and extracellular …

Traumatic brain injury is followed by a cascade of dynamic and complex events occurring at
the cellular level. These events include: diffuse axonal injury, neuronal cell death, blood …